Global Metoclopramide Market 2024-2030

    In Stock





    A drug called methoclopramide is used to treat esophageal and stomach issues. It is frequently used to treat and prevent nausea and vomiting, to assist those who have gastroesophageal reflux disease in having their stomachs empty more quickly, and to treat and prevent nausea and vomiting in healthy individuals.


    Moreover, migraine headaches are treated with it. The anti-sickness drug metoclopramide is used to treat nausea and vomiting.


    It might not be appropriate for some people, such as those who have Parkinson’s disease, epilepsy, high blood pressure, cirrhosis, kidney disease, congestive heart failure, or preexisting gastrointestinal issues (such as haemorrhage, obstruction, or perforation); pheochromocytoma; or a history of intolerance to metoclopramide. 




    Infographic: Metoclopramide Market, Metoclopramide Market Size, Metoclopramide Market Trends, Metoclopramide Market Forecast, Metoclopramide Market Risks, Metoclopramide Market Report, Metoclopramide Market Share


    The Global Metoclopramide Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.



    Metoclopramide Injection Is Introduced by Teva The generic version of Reglan injection made by Baxter, called Metoclopramide Injection, has been introduced by Teva.


    Metoclopramide is an antidopaminergic indicated for relief of symptoms associated with acute and recurrent diabetic gastric stasis, prophylaxis of vomiting associated with emetogenic cancer chemotherapy, prophylaxis of postoperative nausea and vomiting in those circumstances where nasogastric suction is undesirable, to facilitate small bowel intubation in adults and paediatric patients in whom the tube does not pass the pylorus with conventional manoeuvres, and to stimulate gastric emptying and intestinal transit of barium in cases where delayed emptying interferes with radiological examination of the stomach and/or small intestine.


    Metoclopramide works by stimulating motility of the upper gastrointestinal tract without stimulating gastric, biliary, or pancreatic secretions. Along with accelerating gastric emptying and intestinal transit, it also makes the pyloric sphincter and duodenal bulb more relaxed.


    It also increases the tone and amplitude of gastric contractions and the peristalsis of the duodenum and jejunum. Additionally, it raises the lower esophageal sphincter’s resting tone.


    Metoclopramide Injection is available in a 5mg/mL strength in 2mL single-use vials Through many acquisitions that integrated and boosted its expertise in novel and generic medications, as well as new therapeutic areas and markets, Teva saw considerable global growth. Teva is one of the top 15 pharmaceutical firms in the world today and a pioneer in the development of speciality and generic drugs.





    1. How many Metoclopramide are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    2. Cost breakup of a Global Metoclopramide and key vendor selection criteria
    3. Where is Metoclopramide manufactured? What is the average margin per unit?
    4. Market share of Global Metoclopramide market manufacturers and their upcoming products
    5. Cost advantage for OEMs who manufacture Global Metoclopramide in-house
    6. key predictions for next 5 years in Global Metoclopramide market
    7. Average B-2-B Metoclopramide market price in all segments
    8. Latest trends in Metoclopramide market, by every market segment
    9. The market size (both volume and value) of the Metoclopramide market in 2024-2030 and every year in between?
    10. Production breakup of Metoclopramide market, by suppliers and their OEM relationship


    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2024-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2024-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2024-2030
    21 Product installation rate by OEM, 2023
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2023
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
      Your Cart
      Your cart is emptyReturn to Shop